Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Argent BioPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$0.3

2024-06-03

Market Capitalization

$18.4 M

2024-06-03

Revenue

$181 K

FY, 2025

CreditSafe Score

?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

AUDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue297.0K656.0K2.2M3.0M4.7M3.4M891.0K181.0K
Cost of goods sold119.0K357.0K1.9M1.7M2.9M1.9M687.0K137.0K
Gross profit197.0K631.0K848.0K2.2M1.8M2.2M2.3M768.0K
Gross profit margin, %66.3%96.2%38.1%73.5%38.5%65.5%261.4%424.3%
Operating expense total8.8M9.1M12.2M13.5M16.0M16.5M17.7M15.6M
Depreciation and amortization328.0K2.3M5.6M491.0K5.2M3.9M1.3M1.8M
EBITDA(8.6M)(8.4M)(11.4M)(11.3M)(14.2M)(14.2M)(15.3M)(14.9M)
EBITDA margin, %-2897.3%-1287.8%-511.6%-377.6%-299.5%-420.4%-1722.6%-8206.6%
EBIT(8.9M)(10.7M)(17.0M)(11.8M)(19.4M)(18.1M)(16.6M)(16.6M)
EBIT margin, %-3007.7%-1634.1%-762.9%-394.0%-410.0%-535.4%-1867.8%-9184.0%
Interest income192.0K202.0K12.0K8.0K2.0K
Interest expense99.0K136.0K369.0K210.0K257.0K482.0K51.0K
Pre tax profit(9.0M)(11.0M)(19.4M)(15.9M)(20.8M)(21.1M)(17.5M)(17.8M)
Income tax expense27.0K(28.0K)2.0K
Net Income(9.0M)(11.1M)(19.4M)(15.9M)(20.8M)(21.1M)(17.5M)(17.8M)

Footer menu